Alpha Therapy News Today

Astatine is one of the least-studied elements of the Periodic Table, because all isotopes of astatine are unstable, with the longest half-life barely exceeding 8 hours.

ONNAING, France--(BUSINESS WIRE)--Regulatory News:Orano Med (a subsidiary of the Orano Group), a pioneer in the development of targeted alpha therapies for oncology, today laid the foundation stone for its ATLab (Alpha Therapy Laboratory) in Onnaing (France, 59). This will be Europe's first industrial-scale pharmace...

Astatine-211 is a promising alpha emitter for targeted alpha therapy for cancer, but astatine is among the least-studied elements. In this research, scient

CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.

CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.

CNL and ITM announced on Oct. 23 the launch of Actinee Inc., a new joint venture company for the industrial scale production of Actinium-225.

New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale...

GARCHING, Germany, MUNICH Germany and CHALK RIVER, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL),

New company will advance Actinium-225 technologies, quickly secure supply, and construct a new production facility in Canada to produce industrial-scale quantities of rare medical isotope 

On track to report topline data from the Pivotal Phase 3 SIERRA trial for Iomab-B in Q4 2022 Overall survival data from the Actimab-A CLAG-M combination trial...